These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 3069273)

  • 1. [Effects of ceruletide and LH-RH on human sudomotor function].
    Murakami K; Sobue G; Mitsuma T; Sugenoya J; Ogawa T
    Rinsho Shinkeigaku; 1988 Jul; 28(7):797-802. PubMed ID: 3069273
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neurotrophic effect of ceruletide and LH-RH on ventral spinal cord in culture].
    Iwasaki Y; Kinoshita M; Ikeda K; Shiojima T
    Rinsho Shinkeigaku; 1989 Nov; 29(11):1407-9. PubMed ID: 2696615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to LH-RH in men infused with theophylline.
    Gonzalez-Barcena D; Kastin AJ; Schalch DS; Miller MC; Henriques-Espinoza R; Schally AV
    Int J Fertil; 1974; 19(4):207-9. PubMed ID: 4376536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone releasing hormone analogues for contraception.
    Nillius SJ
    Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Effect of synthetic luteinizing hormone-releasing hormone (LH-RH) in the human testicular function.
    Bergadá C; Mancini RE; Rivarola MA; Vilar O; Calamera JC; Mendilaharzu H; Behar B; Bianculli C
    Acta Physiol Lat Am; 1973; 23(6):584-5. PubMed ID: 4153018
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal response to LH-RH application in normal women.
    Cvetković M; Behrman H; Papić N; Sulović V; Genbacev O
    Endokrinologie; 1982 Jul; 80(1):13-7. PubMed ID: 6756899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M; Schally AV; Szepeshazi K; Halmos G; Nagy A
    Clin Cancer Res; 2003 Oct; 9(12):4505-13. PubMed ID: 14555524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
    Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
    Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LH-RH stimulated LH secretion in human endocrine disease.
    Vierhapper H
    Acta Endocrinol Suppl (Copenh); 1985; 269():3-25. PubMed ID: 3931400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased potency of four analogues of LH-releasing hormone in man.
    Kastin AJ; Arimura A; Gonzalez-Barcena D; Coy DH; Miller MC; Nishi N; Lee L; Duron-Huerta H; Schalch DS; Schally AV
    Int J Fertil; 1974; 19(4):202-6. PubMed ID: 4376535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse effects of a potent LH-RH antagonist on the LH and FSH release.
    Kovács M; Koppán M; Mezó I; Teplán I
    Acta Biol Hung; 1994; 45(2-4):285-96. PubMed ID: 7725823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Basal and LH-RH-stimulated gonadotropin release after transport stress in male rats].
    Bieglmayer C; Spona J; Adamiker D; Jettmar W
    Endokrinologie; 1980 Jun; 75(3):304-10. PubMed ID: 6775938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary responsiveness to LH-RH during gestation and puerperium in the rhesus monkey.
    Asch RH; Kotoulas IB; Smith G; Eddy CA; Balmaceda JP
    Acta Eur Fertil; 1984; 15(1):15-23. PubMed ID: 6428125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary response to luteinizing hormone-releasing hormone analog at sea level and high altitudes.
    Paredes Suarez M; Varea Teran JR; Garces G; Avila C; Coy DH; Schally AV
    Obstet Gynecol; 1982 Jan; 59(1):52-7. PubMed ID: 6804897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of serum testosterone and luteinizing hormone levels after cessation of long-term luteinizing hormone-releasing hormone agonist treatment in patients with prostate cancer.
    Kaku H; Saika T; Tsushima T; Ebara S; Senoh T; Yamato T; Nasu Y; Kumon H
    Prostate; 2006 Mar; 66(4):439-44. PubMed ID: 16329145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased sensitivity and partial refractoriness of the human pituitary to repeated synthetic LH-RH stimulations.
    Serra GB; Lafuenti G
    Folia Endocrinol; 1974 Apr; 27(2):158-67. PubMed ID: 4597339
    [No Abstract]   [Full Text] [Related]  

  • 17. Gonadotropin release after administration of LH-RH during early follicular phase.
    Hanker JP; Ende U; Bohnet HG; Schneider HP
    Int J Fertil; 1980; 25(2):100-5. PubMed ID: 6117522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of injection and infusion of LH-RH on serum LH and FSH in normal males and in boys with delayed puberty.
    De Lange WE; Sluiter WJ; Van Zanten AK; Doorenbos H
    Neth J Med; 1974; 17(4-5):196-201. PubMed ID: 4619183
    [No Abstract]   [Full Text] [Related]  

  • 19. Estimation of the degree of damage in gonadotropin secretion in atypical Sheehan's syndrome by the use of the LH-RH test.
    Ayala A; Canales ES; Zárate A; Soria J
    Rev Invest Clin; 1974; 26(4):333-40. PubMed ID: 4617270
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies on basal immunoreactive luteinizing hormone (LH), serum testosterone and pituitary responsiveness to luteinizing hormone releasing hormone (LH-RH) in elderly men.
    Marrama P; Montanini V; Celani MF; Baraghini GF; Carani C; Cavani D; Negri R; Diazzi G
    Minerva Endocrinol; 1984; 9(1):1-6. PubMed ID: 6390119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.